An interventional study of EORTC QLQ-C30 and EORTC QLQ-GI.NET21 in Quality of Life, sponsored by University Hospital, Antwerp. Recruiting at 7 sites in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-03-24.
Sponsored by University Hospital, Antwerp · Not applicable, Interventional, and Treatment
Neuroendocrine tumors (NET) are rare tumors that require specific diagnosis and treatment. Therefore, this poses a challenge for clinical practice. Diagnosis and treatment can be optimized when physician specialists and other healthcare providers, across various hospitals, join forces to provide patients the best care. Based on this idea, a hospital network called NETwerk was set up. The following hospitals are part of this network: University Hospital Antwerp, VITAZ, AZ Monica, AZ Voorkempen, AZ Klina, Gasthuiszusters Antwerpen, Ziekenhuis Netwerk Antwerpen and AZ Rivierenland. In this NETwerk, patients with a neuroendocrine tumor or patients suspected with a neuroendocrine tumor are discussed with the specialists and treated.The aim of this study is to map the quality of life of NET patients within NETwerk in order to optimize the quality of care. Throughout the diagnosis, the treatment process and the follow-up, the patient will be asked to fill out three questionnaires (QLQ-C30, QLQ-GI.NET21 and a satisfaction survey). These questionnaires will be filled out every six months at home. Patients will be asked to complete these questionnaires over a period of five years.
9,365 studies on the registry are indexed under Neoplasms; 2,489 are open to participants now.
This study's planned enrollment of 1,000 is above the median of 50 across 7,253 interventional studies indexed under Neoplasms.
Browse Neoplasms studies →University Hospital, Antwerp is the lead sponsor of 234 studies on the registry; 68 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
EORTC QLQ-C30, EORTC QLQ-GI.NET21 and satisfaction survey
Procedure: EORTC QLQ-C30 · Procedure: EORTC QLQ-GI.NET21 · Procedure: Satisfaction survey
Quality of life questionnaire that has to be completed every 6 months
Quality of life questionnaire that has to be completed every 6 months
Questionnaire regarding satisfaction of care that has to be completed on Day 1.
Quality of life measurement with QLQ-C30 questionnaire
Quality of life measurement with QLQ-C30 questionnaire
Time frame: 5 years
Quality of life measurement with QLQ-GI.NET21 questionnaire
Quality of life measurement with QLQ-GI.NET21 questionnaire
Time frame: 5 years
Quality of care measurement with satisfaction survey
Quality of care measurement with satisfaction survey
Time frame: 5 years
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Antwerp